The T-peak-to-T-end interval: a novel ECG marker for ventricular arrhythmia and appropriate ICD therapy in patients with hypertrophic cardiomyopathy

L Dinshaw, J Münch, J Dickow, S Lezius… - Clinical Research in …, 2018 - Springer
Introduction Hypertrophic cardiomyopathy (HCM) is associated with an increased risk of
sudden cardiac death (SCD) primarily due to ventricular arrhythmia (VA). In patients (pts.) …

The T-peak-to-T-end interval: a novel ECG marker for ventricular arrhythmia and appropriate ICD therapy in patients with hypertrophic cardiomyopathy

L Dinshaw, J Münch, J Dickow… - Clinical research in …, 2018 - pubmed.ncbi.nlm.nih.gov
Introduction Hypertrophic cardiomyopathy (HCM) is associated with an increased risk of
sudden cardiac death (SCD) primarily due to ventricular arrhythmia (VA). In patients (pts.) …

The T-peak-to-T-end interval: a novel ECG marker for ventricular arrhythmia and appropriate ICD therapy in patients with hypertrophic cardiomyopathy

L Dinshaw, J Münch, J Dickow, S Lezius… - Clinical Research in …, 2018 - search.proquest.com
Methods In 40 HCM pts.(51.4±16.4 years; 62.5% men), TpTe was measured using the
baseline digital standard resting 12-lead ECG during sinus rhythm. VA was assessed by …

The T-peak-to-T-end interval: a novel ECG marker for ventricular arrhythmia and appropriate ICD therapy in patients with hypertrophic cardiomyopathy.

L Dinshaw, J Münch, J Dickow, S Lezius… - Clinical Research in …, 2017 - europepmc.org
Methods In 40 HCM pts.(51.4±16.4 years; 62.5% men), TpTe was measured using the
baseline digital standard resting 12-lead ECG during sinus rhythm. VA was assessed by …